TREACE MED CONCEPTS INC shareholders Q3 2023

TREACE MED CONCEPTS INC's ticker is TMCI and the CUSIP is 89455T109. A total of 126 filers reported holding TREACE MED CONCEPTS INC in Q3 2023. The put-call ratio across all filers is 0.48 and the average weighting 0.1%.

TREACE MED CONCEPTS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Lindbrook Capital, LLC 72$9440.00%
Zurcher Kantonalbank (Zurich Cantonalbank) 8,161$106,9910.00%
FMR LLC 1,284$16,8330.00%
ROYAL BANK OF CANADA 6,194$81,0000.00%
Bank of New York Mellon Corp 166,350$2,180,8480.00%
ENVESTNET ASSET MANAGEMENT INC 11,537$151,2500.00%
BANK OF AMERICA CORP /DE/ 81,434$1,067,5990.00%
Citadel Advisors 26,100$342,1710.00%
Citadel Advisors 15,900$208,4490.00%
Citadel Advisors 125,957$1,651,2960.00%
MANUFACTURERS LIFE INSURANCE COMPANY, THE 24,717$324,0400.00%
Legal & General Group Plc 39,581$518,9070.00%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 66,100$866,5710.00%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 25,500$334,3050.00%
Creative Planning 20,315$266,3300.00%
JANUS HENDERSON GROUP PLC 19,809$259,6960.00%
VOYA INVESTMENT MANAGEMENT LLC 18,354$240,6210.00%
VALLEY NATIONAL ADVISERS INC 45$10.00%
SIGNATUREFD, LLC 30$3930.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
External links

This page lists TREACE MED CONCEPTS INC's shareholders in Q3 2023. To view TREACE MED CONCEPTS INC's shareholder history, click here.